Sign up to our newsletter for 20% OFF
NP-III (RT) 12.5MG + Cagrilintide 2.5MG20% Off
≥ 99%
HPLC
MS
COA
Peptides Blends

NP-III (RT) 12.5MG + Cagrilintide 2.5MG

$152$190≥ 99% purity

Size

15MG / vial (12.5MG + 2.5MG)

Form

Research material

Purity

≥ 99%

Storage

-20°C

16 in stock

Quantity pricing

QuantityPrice
1

Limit 10 per order. Ships within 24 hours.

24h dispatch
Secure checkout

For research use only. All products are intended strictly for laboratory research and in-vitro use only. Not for human or veterinary consumption, diagnostic, or therapeutic use. Products are not drugs, foods, cosmetics, or dietary supplements and may not be misbranded, misused, or mislabeled.

Description

This 15MG blend combines NP-III (RT) — NUPEPS PEPTIDES' designation for a research reference material containing GLP-3RT, the triple incretin-receptor agonist peptide — with cagrilintide, the long-acting amylin analog, for integrated metabolic-signaling research. The combination reflects a direction explored in preclinical literature: incretin-receptor pathways (GIP, GLP-1 and glucagon) and amylin-receptor pathways regulate energy balance through distinct, complementary mechanisms, and researchers study their combined versus isolated effects in metabolic models. By formulating both agents at a fixed 12.5MG/2.5MG ratio, this blend lets laboratories run co-administration studies, pathway-interaction comparisons, and receptor-crosstalk experiments with guaranteed proportion consistency across cohorts. Both components are analytically verified for identity and proportion within the blend. The 15MG total quantity (12.5MG NP-III (RT) + 2.5MG cagrilintide) is calibrated for pilot combination studies, letting research groups establish whether the dual-pathway approach merits scale-up before committing larger resources. For laboratory research use only. Not for human or veterinary use.

Research Peptide (NP-III (RT) + Cagrilintide)

Key Features

  • NP-III (RT) and Cagrilintide combination studied in incretin and amylin signaling and peptide-receptor research.
  • 12.5MG/2.5MG formulation provides two research peptides for controlled comparative investigations.
  • Suitable for studies of GIP, GLP-1, glucagon and amylin receptor pathways.
  • Intended exclusively for laboratory and research use.

Frequently asked questions

What is the purity of NP-III (RT) 12.5MG + Cagrilintide 2.5MG?

Review the matching report for NP-III (RT) 12.5MG + Cagrilintide 2.5MG in the COA library. Read the reported method, identity information and purity result together, and match the lot identifier to the supplied material.

Is a Certificate of Analysis included with NP-III (RT) 12.5MG + Cagrilintide 2.5MG?

Browse the published COA library for NP-III (RT) 12.5MG + Cagrilintide 2.5MG. Confirm that an available report matches the supplied product and lot; contact NUPEPS for current batch documentation before purchase.

How fast is shipping for NP-III (RT) 12.5MG + Cagrilintide 2.5MG?

Orders placed before 3PM EST ship the same business day from our USA facility. Estimated delivery is 2 business days. Flat $15 shipping per order.

Is NP-III (RT) 12.5MG + Cagrilintide 2.5MG for human use?

No. NP-III (RT) 12.5MG + Cagrilintide 2.5MG is strictly for laboratory research use only. Not for human or veterinary consumption, diagnostic, or therapeutic use.

Research guides

Explore background and published research related to this compound.